A MODEL FOR ASSESSMENT OF TELEMEDICINE APPLICATIONS: MAST

Objectives: Telemedicine applications could potentially solve many of the challenges faced by the healthcare sectors in Europe. However, a framework for assessment of these technologies is need by decision makers to assist them in choosing the most efficient and cost-effective technologies. Therefore in 2009 the European Commission initiated the development of a framework for assessing telemedicine applications, based on the users’ need for information for decision making. This article presents the Model for ASsessment of Telemedicine applications (MAST) developed in this study. Methods: MAST was developed through workshops with users and stakeholders of telemedicine. Results: Based on the workshops and using the EUnetHTA Core HTA Model as a starting point a three-element model was developed, including: (i) preceding considerations, (ii) multidisciplinary assessment, and (iii) transferability assessment. In the multidisciplinary assessment, the outcomes of telemedicine applications comprise seven domains, based on the domains in the EUnetHTA model. Conclusions: MAST provides a structure for future assessment of telemedicine applications. MAST will be tested during 2010–13 in twenty studies of telemedicine applications in nine European countries in the EC project Renewing Health.

[1]  D. Hailey,et al.  Systematic review of evidence for the benefits of telemedicine , 2002, Journal of telemedicine and telecare.

[2]  T. L. Williams,et al.  Systematic review of cost effectiveness studies of telemedicine interventions , 2002, BMJ : British Medical Journal.

[3]  Michael Drummond,et al.  Economic evaluation for devices and drugs--same or different? , 2009, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

[4]  C. Urquhart,et al.  Telemedicine versus face to face patient care: effects on professional practice and health care outcomes. , 2000, Nursing times.

[5]  James Wallace,et al.  Clinical outcomes resulting from telemedicine interventions: a systematic review , 2001, BMC Medical Informatics Decis. Mak..

[6]  Richard E Scott,et al.  Telehealth outcomes: a synthesis of the literature and recommendations for outcome indicators. , 2007, Journal of telemedicine and telecare.

[7]  A. D. Fisk,et al.  Human factors considerations in implementing telemedicine systems to accommodate older adults , 2007, Journal of Telemedicine and Telecare.

[8]  Andrea Manca,et al.  Increasing the generalizability of economic evaluations: Recommendations for the design, analysis, and reporting of studies , 2005, International Journal of Technology Assessment in Health Care.

[9]  D Hailey,et al.  ELEMENTS FOR ASSESSMENT OF TELEMEDICINE APPLICATIONS , 2001, International Journal of Technology Assessment in Health Care.

[10]  Alison Bowes,et al.  Effectiveness of telemedicine: A systematic review of reviews , 2010, Int. J. Medical Informatics.

[11]  M. Petticrew,et al.  Developing and evaluating complex interventions: the new Medical Research Council guidance , 2008, BMJ : British Medical Journal.

[12]  Douglas G. Altman,et al.  Systematic Reviews in Health Care , 2001 .

[13]  D. Moher,et al.  Transparent and accurate reporting increases reliability, utility, and impact of your research: reporting guidelines and the EQUATOR Network , 2010, BMC medicine.

[14]  M. Scriven.  Evaluation thesaurus, 4th ed. , 1991 .

[15]  Jan Stentoft Arlbjørn.  Process optimization with simple means: the power of visualization , 2011 .

[16]  W. Hersh,et al.  Telemedicine for the medicare population: update. , 2006, Evidence report/technology assessment.

[17]  M. Pittler.  Systematic Reviews in Health Care: Meta‐analysis in Context , 2010 .

[18]  Paul Taylor,et al.  Evaluating telemedicine systems and services , 2005, Journal of telemedicine and telecare.

[19]  Finn Børlum Kristensen,et al.  The HTA Core Model: A novel method for producing and reporting health technology assessments , 2009, International Journal of Technology Assessment in Health Care.